共 50 条
- [22] Exploring Autoantibodies as Predictors of Severe Fibrosis or Cirrhosis in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Response CANADIAN LIVER JOURNAL, 2024, 7 (04): : 417 - 418
- [23] Epidemiology of metabolic dysfunction-associated steatotic liver disease (MASLD) and alcohol-related liver disease (ALD) METABOLISM AND TARGET ORGAN DAMAGE, 2024, 4 (04):
- [27] Evaluation of liver fibrosis and steatohepatitis associated with metabolic dysfunction (MASH) in patients with inflammatory bowel disease (IBD) and steatotic liver disease associated with metabolic dysfunction (MASLD) JOURNAL OF CROHNS & COLITIS, 2025, 19 : i666 - i666